JESSICA WESTPHAL: Open Payments
NPI 1609502939 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 34 payments from 17 companies in 2025. Trend: 2023 $774 · 2024 $610 · 2025 $787
Food & beverage: $660Education: $127
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $144 |
| ABBVIE INC. | 3 | $71 |
| Novo Nordisk Inc | 3 | $54 |
| PFIZER INC. | 3 | $51 |
| Cipher Pharmaceuticals US LLC | 1 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: Auvelity, JARDIANCE, ELIQUIS, Natroba, QULIPTA, FANAPT, EOHILIA, Kerendia.
Industry payments across MI — which companies pay providers there.
